UK markets closed

DBVT May 2024 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 04:47PM EDT. Market open.
Full screen
Previous close0.0500
Open0.0500
Bid0.0000
Ask0.2500
Strike2.50
Expiry date2024-05-17
Day's range0.0500 - 0.0500
Contract rangeN/A
Volume1
Open interest37
  • GlobeNewswire

    Combined General Meeting of May 16, 2024

    Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “Company”), will hold its Combined General Meeting (the “General Meeting”) on May

  • GlobeNewswire

    Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

    Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights03/31/2024 96,434,369 Total gross of voting rights: 96,434,369 Total net* of voting rights: 96,171,725 * Net total = total number of voting rights attached to shares – shares without voti

  • Insider Monkey

    DBV Technologies S.A. (NASDAQ:DBVT) Q4 2023 Earnings Call Transcript

    DBV Technologies S.A. (NASDAQ:DBVT) Q4 2023 Earnings Call Transcript March 7, 2024 DBV Technologies S.A. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Apologies for the late start of our conference. Welcome to the DBV Full Year 2023 Financial Results […]